concept

placenta

Semantic SEO entity — key topical authority signal for placenta in Google’s Knowledge Graph

The placenta is a temporary, multifunctional organ that develops in the uterus during pregnancy, connecting the developing fetus to maternal circulation via the umbilical cord. It mediates nutrient and gas exchange, produces hormones, and supports immune tolerance — making it central to fetal growth, pregnancy outcome, and prenatal nutrition strategies. For content strategy, placenta coverage attracts clinical, nutritional, and parental-search intent and unlocks topical authority across prenatal health, pregnancy complications, and dietary guidance.

Typical term weight
Mean ~500 g (range ~450–600 g) at 37–42 weeks gestation
Average dimensions
Diameter ~15–20 cm, thickness ~2–3 cm at term
Umbilical cord vessels
Usually 3 vessels: 2 umbilical arteries and 1 umbilical vein
Development timeline
Formed from trophoblast after implantation; functional endocrine activity by ~6–10 weeks, fully supports placenta–fetal exchange by second trimester
Key hormones produced
hCG, progesterone, estrogens (estriol), human placental lactogen (hPL), and placental growth factors
Common complications prevalence
Placenta previa ~0.3–0.5% at term; placental abruption ~0.25–1%; preeclampsia related to abnormal placentation in ~2–8% of pregnancies
IgG transfer timing
Majority of maternal IgG transfer occurs in the third trimester (after ~28 weeks), increasing fetal passive immunity

Structure and physiology of the placenta

The placenta is composed of fetal-derived chorionic villi bathed in maternal blood within the intervillous space; these villi house fetal capillaries that facilitate exchange across a thin syncytiotrophoblast layer. Microscopically, the functional unit is the villous tree, supported by cytotrophoblast and syncytiotrophoblast layers that regulate nutrient transport, hormone secretion, and barrier function.

Maternal blood enters the intervillous space via spiral arteries remodeled by invasive extravillous trophoblast cells early in pregnancy. This remodeling lowers vascular resistance and establishes a high-flow, low-pressure system optimized for exchange; failure of adequate remodeling is implicated in preeclampsia and fetal growth restriction.

Transport mechanisms include simple diffusion (oxygen, CO2), facilitated diffusion (glucose via GLUT transporters), active transport (amino acids), endocytosis (maternal IgG via Fc receptors), and receptor-mediated transport for some lipids and micronutrients. The placenta also metabolizes substrates — for example, partially oxidizing glucose to lactate that the fetus can use — and expresses detoxifying enzymes with limits to barrier protection.

Functions: nutrition, gas exchange, endocrine support, and immune roles

Primary functions include delivering oxygen and nutrients from maternal blood to the fetus and removing fetal waste products. Oxygen transfer depends on maternal oxygenation, uteroplacental blood flow, and placental surface area; pathologies that reduce flow or surface (e.g., infarcts, maternal vascular disease) impair fetal oxygenation and growth.

Endocrine function is central: the placenta produces hCG early in pregnancy to maintain corpus luteum function, then increases progesterone and estrogens to support uterine quiescence and maternal cardiovascular adaptations. Human placental lactogen modulates maternal metabolism, promoting lipolysis and insulin resistance to increase glucose availability for the fetus.

Immunologically, the placenta mediates fetal tolerance: trophoblast cells lack classical HLA-A/B expression and express HLA-G to reduce maternal T-cell and NK-cell attack. The placenta also selectively transfers maternal IgG antibodies, providing neonatal immunity, and serves as a site where maternal infections may cross or be blocked depending on pathogen characteristics.

Clinical conditions, diagnostics, and pathology

Abnormal placentation includes placenta previa (placenta implants near or over the cervical os), placenta accreta spectrum (abnormally adherent/invasive placenta), and vasa previa (fetal vessels over the internal os). Each carries specific maternal–fetal risks: hemorrhage, need for cesarean hysterectomy, and fetal exsanguination, respectively. Prevalence: placenta previa ~0.3–0.5% at term; accreta spectrum risk rises with uterine surgery and placenta previa.

Placental insufficiency and maternal vascular malperfusion are common pathological correlates of fetal growth restriction and stillbirth. Clinicians evaluate suspected problems with ultrasound (placental location, cord insertion, Doppler of uterine and umbilical arteries), maternal labs, and fetal monitoring. After adverse outcomes (stillbirth, neonatal death, severe preterm birth), placental gross and histologic examination is recommended to identify infarcts, infection, inflammation (chorioamnionitis), or thrombotic lesions.

Acute events include placental abruption (premature separation), typically presenting with pain and bleeding and affecting ~0.25–1% of pregnancies. Chronic lesions include chronic villitis and maternal-fetal thrombotic disorders, which may prompt further maternal thrombophilia or infectious work-up depending on findings.

Placenta and prenatal nutrition: transfer, deficiencies, and supplementation implications

The placenta actively transports macronutrients and micronutrients; deficiencies or excesses in maternal diet can directly affect fetal supply. For example, iron crosses via transferrin receptor-mediated pathways — maternal iron deficiency anemia increases risk for inadequate fetal iron stores and may prompt higher-dose prenatal iron supplementation. Folate and B12 are critical for neural development; placental folate transport mechanisms concentrate folate for the fetus.

Micronutrients with placenta-mediated concerns include iodine (essential for fetal thyroid hormone production; deficiency linked to neurodevelopmental impairment), vitamin D (placental vitamin D–metabolizing enzymes exist and may influence fetal bone development and immune programming), and omega-3 long-chain polyunsaturated fatty acids (DHA concentrates in the fetal brain; maternal supplementation is associated with modest benefits in reducing preterm birth in some trials).

Clinically, dietary counseling and evidence-based supplementation (iron, folic acid, possibly DHA) are standard components of prenatal care because maternal stores and intake are the primary modifiable determinants of fetal nutrient supply. However, the placenta has selective limits — e.g., certain large molecules and pathogens may cross inefficiently or not at all — and supplementation cannot fully overcome severe placental insufficiency caused by vascular pathology.

Postnatal handling, placentophagy, and controversies

After delivery, the placenta is typically inspected by the birth team for completeness and signs of pathology. Many hospitals consider the placenta medical tissue; institutional policies govern requests for parental retention or release for cultural practices. Placental pathology is sent to a lab when indicated (stillbirth, preterm delivery, severe neonatal complications) to guide postpartum care and recurrence risk counseling.

Placenta consumption (placentophagy) and encapsulation have grown in popularity in some communities. The scientific evidence for maternal benefits (mood, energy, lactation) is extremely limited and inconsistent; major obstetric organizations note insufficient evidence to recommend ingestion. There are documented risks: case reports of neonatal infection after maternal ingestion of contaminated preparations and lack of standardized processing raise safety concerns.

Regulatory and research gaps persist: the placenta is a unique transient organ with growing research on its role in developmental origins of health and disease (DOHaD). Researchers study placental transcriptomics, epigenetics, and metabolomics to understand how maternal nutrition, exposures, and placental function program lifelong child health.

Content Opportunities

informational How the Placenta Transports Nutrients: What Pregnant People Need to Know
informational Placenta Encapsulation: Risks, Evidence, and Safety Protocols
informational Placental Insufficiency and Diet: Nutritional Strategies to Support Fetal Growth
informational Placenta Previa vs. Placental Abruption: Signs, Diagnosis, and Delivery Planning
informational Which Prenatal Supplements Cross the Placenta? A Guide to Iron, Folate, Vitamin D, and DHA
informational When to Send a Placenta to Pathology: Hospital Protocols and What the Findings Mean
informational Placenta Hormones and Mood: Understanding hCG, hPL, and Postpartum Changes
informational Evidence Review: Does Maternal DHA Supplementation Improve Placental Function?
informational Placental Growth Factor (PlGF) Tests: When They're Used in Pre-eclampsia Workup
transactional How to Talk to Your OB About Placenta Retention or Donation

Frequently Asked Questions

What is the placenta and what does it do?

The placenta is a temporary organ that forms during pregnancy to connect the fetus to the mother's uterus. It transports oxygen and nutrients, removes fetal waste, produces hormones to sustain pregnancy, and mediates immune tolerance between mother and fetus.

When does the placenta form in pregnancy?

Placental development begins immediately after implantation from trophoblast cells; basic endocrine activity starts in the first trimester, and the organ is fully functional for growth and exchange by the second trimester.

How does the placenta affect fetal nutrition?

The placenta actively transports glucose, amino acids, fatty acids, and micronutrients to the fetus using diffusion, facilitated and active transport mechanisms. Maternal diet and nutrient stores influence what the placenta can deliver, though placental pathology can limit transfer regardless of maternal intake.

Is it safe to eat the placenta after birth?

Current evidence does not support clear health benefits from placentophagy, and there are case reports of infections linked to contaminated preparations. Major obstetric organizations state there is insufficient evidence to recommend it and advise caution.

What are common placental problems to watch for?

Key issues include placenta previa (low-lying placenta), placenta accreta spectrum (abnormal adherence/invasion), placental abruption (premature separation), and placental insufficiency leading to fetal growth restriction. Many are identified via ultrasound and clinical signs like bleeding or fetal growth concerns.

How is the placenta examined after delivery?

A routine gross inspection ensures the placenta is complete; pathology examination (gross and microscopic) is done when there are adverse outcomes such as stillbirth, preterm birth, neonatal complications, or suspicion of infection to identify lesions and guide further maternal/fetal evaluations.

Does the placenta prevent infections from reaching the fetus?

The placenta acts as a partial barrier and blocks many pathogens, but certain viruses (Zika, CMV), bacteria (Listeria under some conditions), and parasites can cross. Risk depends on pathogen type, maternal immune status, and placental integrity.

How does the placenta influence pregnancy-related hormones?

The placenta synthesizes and secretes hormones including hCG (early pregnancy support), progesterone and estrogens (sustaining pregnancy and maternal physiology), and hPL (modifying maternal metabolism to favor fetal nutrient supply).

Topical Authority Signal

Thoroughly covering the placenta signals comprehensive prenatal care and biological expertise to Google and LLMs, aligning your content with clinical, nutritional, and parental search intents. Deep, evidence-based placenta content unlocks topical authority across pregnancy complications, prenatal nutrition, and neonatal outcomes.

Topical Maps Covering placenta

Browse All Maps →